ArticlePDF Available

A case of idiopathic nephrotic syndrome treated with the homeopathic therapeutic

Authors:

Abstract and Figures

p class="IJHDRabstract" style="margin: 0cm 1cm 6pt;"> Nephrotic syndrome is a chronic clinical condition and drugs used in its treatment may result in severe side-effects. Renal transplantation or renal ablation and subsequent chronic dialysis treatment may be the only feasible way to patients. The present article reports the case of a 23-years-old white woman that presented nephrotic syndrome and was successfully treated with homeopathic medicines. Six kind of homeopathic diagnoses were made to build the clinical homeopathic picture of the patient and to determine the appropriate medicines, according to the clinical protocol used. Apis mellifica was the main medicine used to treat the diathesis sycosis. The satisfactory treatment outcome shows that the judicious homeopathic therapeutic may be a valuable resource in the treatment of nephrotic syndrome. </p
Content may be subject to copyright.
Int J High Dilution Res 2009; 8(26):26-32
26
Case Report
A case of idiopathic nephrotic syndrome treated with
the homeopathic therapeutic
Luiz Figueira Pinto
Federal Rural University of Rio de Janeiro, RJ, Brazil
ABSTRACT
Nephrotic syndrome is a chronic clinical condition and drugs used in its treatment may result in
severe side-effects. Renal transplantation or renal ablation and subsequent chronic dialysis
treatment may be the only feasible way to patients. The present article reports the case of a 23-
years-old white woman that presented nephrotic syndrome and was successfully treated with
homeopathic medicines. Six kind of homeopathic diagnoses were made to build the clinical
homeopathic picture of the patient and to determine the appropriate medicines, according to the
clinical protocol used. Apis mellifica was the main medicine used to treat the diathesis sycosis.
The satisfactory treatment outcome shows that the judicious homeopathic therapeutic may be a
valuable resource in the treatment of nephrotic syndrome.
Keywords: Nephrotic syndrome; Clinical protocol; Diathesis; Sycosis; Homeopathy
Introduction
Nephrotic syndrome is a chronic clinical condition
characterized by proteinuria, hypoalbuminemia,
edema, and hypercholesterolemia. Edema is the
predominant feature, and in time it becomes
generalized and may be associated with the
increase in weight, development of ascitic or
pleural effusion, and decline in urine output. It is
more common in children than in adults [1, 2].
Drugs used in the treatment of nephrotic
syndrome include corticosteroids,
immunomodulators, immunosuppressant, diuretics
and antibiotics. The response to these drugs
depends on the cause of nephrotic syndrome. These
treatments may result in severe side-effects, and
there are some contraindications for their use [1, 2,
3]. Renal transplantation or renal ablation and
subsequent chronic dialysis treatment may be the
only feasible way to help patients that showed
resistance to the other treatments [4].
Complementary and alternative therapies are
increasingly been used in a variety of clinical
conditions with successful results [5, 6].
The present article reports the case of a 23-years-
old white woman that presented nephrotic
syndrome and was successfully treated with
homeopathic medicines.
Case report
The disease process started 29 months before the
first homeopathic attendance, with swelling of the
feet that evolved into ascites. Spontaneous
remission had occurred previously on two
occasions,. On that time, the idiopathic nephrotic
syndrome was diagnosed after biopsy (performed
at University Hospital Clementino Fraga Filho,
Federal University of Rio de Janeiro) and the
treatment was initiated in February 2003 and
finished in August 2004, including Prednisone
(20mg/day), Furosemide (40mg/day),
Hidroclorotiazide (25mg/day), Simvastatin
(20mg/day), Cyclophosphamide (50mg/day),
Captopril (12,5mg/ day), Levofloxacin
(500mg/day), Levamisole hydrochloride and
Vitamin A and D, at different times., without
clinical response. After a few months, renal
transplantation was recommended and the patient
was left without further treatment waiting for a
compatible donor. In the meanwhile, she sought
several complementary and alternative therapies,
including orthomolecular medicine, blood-group
diet and homeopathy, all equally unsuccessful.
This treatment was realized in another service and
occurred from October 2004 to April 2005. The
patient presented with failure labor since October
Int J High Dilution Res 2009; 8(26):26-32
27
2003 and received a disability retirement in
January 2005.
The first homeopathic attendance was in June
2005, the patient presented severe swelling in the
legs and ascites. She was overweight and her urine
was foamy. She was prostrated and would only
leave the bed or couch to go to the bathroom.
(Figure 1) At that time, she was not taking any
medicine. Her mother brought her to the
attendance compulsorily and she was irritated,
frightened and discouraged and did not bring the
results of the laboratory tests. She was very
frustrated and disappointed, and appeared to
refuse to remember her clinical history. Her
mother told me she had proteinuria,
hypoalbuminemia and hypercholesterolemia.
Figure 1: patient with swollen legs and ascites.
Significant antecedents included: menarche at 12
years old, and absence of menstrual periods for
more than six months; asthma since she was two
years old; measles at eight years old, occasional
tonsillitis and flu; and allergy to dipyrone. The
family history did not reveal significant data.
On physical examination were registered arterial
hypertension (160/100mmHg) , severe
swelling of the legs associated with increase in
weight (from 63 to 110 kg) and loss of muscular
mass in the arms; lumbar lordosis and felon on the
right halux. Her body was of regular aspect, the
angle between arm and forearm was 180
0
, and
costal-external angle was 90
0
.
Homeopathic approach was the one described by
Pinto [7] and the following diagnoses were
established: 1) Clinical: idiopathic nephrotic
syndrome; 2) Dynamic clinical prognosis: severely
lesional to incurable; 3) Biopathographic factors:
pathological personal history; 4) Biotypologic:
sulphuric; 5) Temperamental: atrabiliary; 6)
Diathesic: sycosis and tuberculinism.
Symptoms selected and repertory correlations are
described in Table 1. Repertory analysis was made
with a repertorial homeopathic system [8], and
results pointed out to Arsenicum album, Apis
mellifica, Mercurius solubilis, Lachesis muta, Kali
carbonicum, Calcarea ostrearum, Pulsatilla
nigricans, Lycopodium clavatum, China officinalis,
and Natrum muriaticum.
.
Table 1: Symptoms selected and repertory correlations
Clinical symptoms
Repertory rubrics
Anxiety for the future
Mind, anxiety future about
Weeps easily
Mind, weeping tearful mood
Jealousy
Mind, jealousy
Desire for company
Mind, company desire alone aggravation
Ailments from bad news
Mind, ailments bad news
Sadness
Mind, sadness depression
Swollen abdomen
Abdomen, hidropsy, ascites
Swollen legs
Extremities, swelling hydropsical edematous
Albuminuria
Extremities, swelling lower limbs hydropsical
albuminúria in
Felon
Extremities, felon panaritium
Swelling in general
Generalities, swelling general in
Anemia
Generalities, anemia
Int J High Dilution Res 2009; 8(26):26-32
28
Table 2: Clinical progress and management
[AC: abdominal circunference (cm); BP: blood-pressure (mmHg)]
Date
Clinical Evolution
Physical examination
Prescription
06/08/05
After visiting the psychologist,
she felt worst; had nightmares
involving doctors. Sleep and
bowels motions improved; urine
less foamy. More frightened and
discouraged.
Swollen legs and face;
pale conjunctivae.
AC: 130; BP: 120/90
Natrum sulphuricum
(Nat-s) 6cH at
morning + Kidney 6cH
at night, once daily.
06/15/05
Can stretch her legs; still
irritated and frightened.
Face no longer swollen;
pale conjunctivae; AC:
123; BP: 140/90
The same.
06/22/05
Anguished due to inflammation
and perspiration on right leg.
Has discontinued homeopathy
and took diuretics for two days
without improvement.
Swollen legs and ascites;
pale conjunctivae; AC:
123; BP: 140/100
Tuberculinum of Koch
(TK) 30cH at morning
+
Berberis vulgaris
(Berb-v) 6cH at night,
once daily.
07/06/05
Frequent and copious urination;
better appetite; thinner;
perspiration on right leg.
Brought laboratory exams.
Swollen legs and ascites;
pale conjunctivae;
proteinuria: +++;
BP: 140/90.
The same.
07/20/05
Feeling better; can use the
shower standing; abdomen is
softer; frequent and copious
urination; cramps in feet.
Swollen legs and ascites;
pale conjunctivae; AC:
130; BP: 150/100
Kidney 6cH, once daily.
08/03/05
Asthma crisis with fear of death.
Swollen legs and ascites;
adenopathy on left side of
the neck.
Adrenal 6cH + Kidney
6cH + Berb-v 6cH +
TK 30cH + Iodium 6cH
+, once daily.
08/12/05
Discouraged; cannot watch TV
nor read magazines for religious
reasons.
Swollen legs and ascites;
pale conjunctivae; BP:
140/90; Weight: 110kg
Nat-s 6cH + Kidney
6cH twice a day.
Asked urine exam.
08/22/05
Right leg inflamed and
perspiring; frightened but
hopeful. Did not make urine
exam.
Vesicular eruption on
right leg (Figure 2); pale
conjunctivae; proteinuria:
+ ; BP: 140/90; Weight:
102kg.
Nat-s 6ch + Kidney
6cH once daily.
09/16/05
Can lie on abdomen; stands up
quickly. Has been eating many
eggs and mayonnaise.
Quick responses; pale
conjunctivae; lumbar
lordosis and legs swelling
diminished; BP: 150/90
Nat-s 6cH + Cortisone
6cH at 8 a.m. and 6
p.m.
10/14/05
Anxiety about her health; hopes
to be well by Christmas.
Scabs on right leg; full-
blooded lips and
Cortisone 6cH at 8 a.m.
and 6 p.m. + Adrenal
Int J High Dilution Res 2009; 8(26):26-32
29
conjunctivae; neck
adenopathy healed;
recovery of muscular
mass in arms; BP: 140/90;
Weight: 103kg
6cH at 8 a.m. +
Nat-s 6cH at 6 p.m. +
Apis 6cH at night.
Asked lab exams.
10/22/05
Home call: intense headache and
fear of death.
Very anxious; weight:
98kg
Magnesia sulphurica
(Mag-s) 6cH twice a
day.
10/24/05
After headache, asthma crisis;
she attributed it to the exposure
to draft after showering.
Dyspnea and wheezing;
Proteinuria: ++.
Arsenicum album (Ars-
a) 6cH, nebulization 3
times daily
11/09/05
Frightened due to headache
after a row with her brother.
BP: 140/100; weight: 92kg
Mag-s 6cH, twice a
day.
11/14/05
After headache, severe
abdominal pain and diarrhea,
asked her parents to hold her
belly.
BP: 110/70; weight: 90kg
Apis 6cH, once daily.
12/7/05
Physically better but
psychologically unwell; very
needy of her parents;
complaining and waiting for
Christmas.
BP: 120/80; weight: 84kg
The same.
12/28/05
Well at Christmas, but angry
about the previous weekend.
BP: 120/80; weight: 74kg
The same.
01/11/06
Well at New Year’s party; urine
is still foamy.
Legs are thin and
wrinkled; BP: 140/80;
weight: 65kg
Apis 30cH once daily.
Lab exams requested.
01/26/06
Angry and weak; headache
extending to face and eyes,
worse on the right side. Has not
made lab exams requested.
BP: 120/70; weight: 59kg
The same.
02/15/06
Toothache extending to the right
side of the body and diplopia;
frightened.
3
rd
molar inflamed, facial
sensitiveness, right
horizontal strabismus
(Figure 3). Lab
tests:hypoalbuminemia:
1.2 g/dL; proteinuria:
+++; BP: 140/80; weight:
58kg
Arnica 6cH + Silicia
6cH + Calc-p 6cH +
Calc-f 6cH, once daily.
03/01/06
03/15/06
Feeling well despite the
toothache and diplopia.
BP: 140/90; weight: 57kg
The same + Adrenal
6cH. Urine exam
requested.
04/15/06
At her birthday party overate
until feeling ill. Urine is still
foamy.
Urine exam: proteinuria
(++). Weight: 53kg
Apis 6cH +
Nat-s 6cH,
Once daily.
05/17/06
“She’s again who she was”, said
her mother. Very happy, lust for
life. Menstruation came back.
Weight: 58kg
Without medication.
Int J High Dilution Res 2009; 8(26):26-32
30
07/12/06
Toothache.
Magnesia carbonica
6cH + Arnica 6cH +
Silicia 6cH + Calc-p
6cH + Calc-f 6cH,
once daily.
08/09/06
Menstruated in July and
August, with swelling and
unwell.
Apis 6cH once daily.
10/18/06
No clinical complaints (Figure 4).
BP: 120/80; weight: 65kg
Discharge.
Based on the diagnoses established, it was
prescribed Apis mellifica 6cH and Berberis
vulgaris 6cH once daily. Clinical progress and
management are described in Table 2. All
medicines were taken in the dosage of five tablets.
Figure 2: patient with vesicular eruption on right
leg.
Figure 3: patient with right horizontal
strabismus.
Figure 4: patient after treatment.
Discussion
The patient had a clinical diagnosis of idiopathic
nephrotic syndrome based on the laboratory
findings of anemia and albuminuria and focal
segmental glomerulosclerosis, which is the most
common form of glomerulopathy causing nephrotic
syndrome in adults [1,2], and determines a poor
prognosis [9]
Six diagnoses were made to build the clinical
homeopathic picture of the patient and to
determine the adequate medicines to be
prescribed, according to clinical protocol employed
[7].
Regarding biopathographic aspects, the patient
had a history of chronic dynamic diseases, possibly
sycosis (measles, tonsillitis and flu), tuberculinism
(asthma), and psora (allergies) [7, 10, 11].
Int J High Dilution Res 2009; 8(26):26-32
31
Nephrotic syndrome was classified as sycosis and
was prescribed Apis mellifica 6cH and Berberis
vulgaris 6cH to promote kidney stimulation. This
procedure resulted in clinical aggravation,
according to first or second Kent`s prognosis [12],
recorded by increasing the swelling of the face and
extremities, and worsening of the psyche.
Therefore, the diathesic medicine was interrupted
and administered the constitutional (Natrum
sulphuricum 6cH) and the biotherapic (Kidney
6cH, Adrenal 6cH and Cortisone 6cH) medicines at
different times. This procedure can be performed
when there are serious organ dysfunctions [7].
As the patient did not improve, and based on her
personal history and the occurrence of asthma and
adenopathy, the presence of tuberculinism was
considered. . In these cases, when dissimilar
diseases occur [13], it is necessary to treat the
dominant chronic disease first [7, 10]. Thus,
Tuberculinum of Koch 30cH, Iodium 6cH and
Arsenicum album 6cH were prescribed at different
times. After this, the clinical improvement started
to be shown by weight loss, full-blooded lips and
conjunctivae, and recovery of muscular mass in
arms.
Despite the clinical evolution, swollen legs, ascites
and albuminuria remained. Therefore, was
prescribed Apis mellifica (6cH and 30cH) to finish
the sycosis treatment. Consequently, the
resumption of growth of the mandibular third
molar tooth, the recovery of body weight and
muscular mass in arms, and the return of the
menstrual flow were observed, characterizing the
recovery of the sanguine temperament which
corresponds to the biological age of the patient [7].
The growth of the mandibular third molar tooth
caused an inflammatory process adjacent to the
trigeminal nerve root that resulted in toothache,
headache and strabismus. These clinical
manifestations were treated with circumstantial
medicines [14].
Remission or relapse of nephrotic syndrome can
happens after corticosteroids and cytotoxic drugs
treatment [15]. Nevertheless, this patient showed
the most common change renal (membranous
glomerulonephritis) after two spontaneous
remission and no responded to conventional
treatment. In spite of her poor prognosis the
clinical remission occurred after judicious
homeopathic treatment and there was no relapse
during the 28-month follow-up. Similarly, in a case
reported about the homeopathic treatment of
vaginal leiomyoma in a dog, considered clinically
incurable, in which the same clinical protocol was
used, the clinical remission was also demonstrated
[16]. The fact that this protocol has been described
in veterinary medicine means that it is an
objective method whose results were destitute of
placebo effect. This makes it reliable to be used in
humans patients.
Conclusions
Nephrotic syndrome is a chronic dynamic disease
which requires specific treatment to the diathesis
sycosis.
The satisfactory outcome in this case shows that
the judicious homeopathic therapeutic may be a
valuable resource in the treatment of nephrotic
syndrome.
References
[1] Harrison TR. Medicina Interna. 15
th
ed, Rio de
Janeiro (Brazil): Mc Graw Hill; 2002.
[2] Agraharkar M, Gala G, Gangakhedkar AK.
Nephrotic syndrome. emedicine [online]. 2007 Feb
1 [cited 2007 Feb 10]. [about 20 p]. Available from:
http://emedicine.medscape.com/article/244631-
overview.
[3] Schieppati A, Perna A, Zamora J, Giuliano GA,
Braun N, Remuzzi G. Immunosuppressive
treatment for idiopathic membranous nephropathy
in adults with nephrotic syndrome. Cochrane
Database of Systematic Reviews [online]. 2004;
Issue 4. [Art. No.: CD004293]. [DOI:
10.1002/14651858.CD004293.pub2]. Available from:
http://www.cochrane.org/reviews/en/ab004293.html
[4] Schwarz A. New aspects of the treatment of
nephrotic syndrome. J Am Soc Nephrol. 2001; 12:
S44S47.
[5] Jonas WB, Anderson RL, Crawford CC, et al. A
systematic review of the quality of homeopathic
clinical trials. BMC Compl Alternative Med
[online]. 2001; 1. [DOI:10.1186/1472-6882-1-12].
Available from: www.biomedcentral.com/1472-
6882/1/12.
[6] Ernst E, Pittler MH. Efficacy of homeopathic
arnica: a systematic review of placebo-controlled
clinical trials. Arch Surg [online]. 1998 [cited 2007
Aug 22]; 133. [about 5 p]. Available from:
http://archsurg.ama-
assn.org/cgi/content/full/133/11/1187.
[7] Pinto LF. Homeopathic veterinary clinical
protocol. In: Bonamin LV, editor. Signals and
images II: contributions and contradictions about
high dilution research. New York (United States):
Springer; 2008.
[8] Favilla JP. SIHORE: Sistema de homeopatia
repertorial Versão 2004 [CD-Rom]. São Paulo;
SIHORE; 2004.
Int J High Dilution Res 2009; 8(26):26-32
32
[9] Mendoza SA, Tune BM. Management of the
difficult nephrotic patient. Pediatr Clin North Am.
1995; 42: 1459-1468.
[10] Carillo Junior R. The law of similarity,
dissimilarity and physiology The principles for
the comprehension of chronic diseases and their
homeopathic treatment. Braz Homeopathic J.
2002; 8(2): 92-102.
[11] Kossak-Romanach A. Homeopatia em 1000
conceitos. 3
rd
ed, São Paulo (Brazil): Elcid; 2003.
[12] Kent JT. 1849-1916. Lectures of
Homoeopathic Philosophy. New Delhi (India): B
Jain; 1987.
[13] Hahnemann S.1755-1843. Organon da arte de
curar. 2
nd
ed, Ribeirão Preto (Brazil): Museu de
Homeopatia Abrahão Brickmann; 1995.
[14] Vannier L, Poirier J. Tratado de Matéria
Médica Homeopática. 9
nd
ed, São Paulo (Brazil):
Andrei; 1987.
[15] Nolasco F, Cameron JS, Heywood EF, Hicks J,
Ogg C, Willians DG. Adult-onset minimal change
nephrotic syndrome: A long-term follow-up. Kidney
Int. 1986; 29: 1215-1223.
[16] Ferreira MIC, Pinto LF. Homeopathic
treatment of vaginal leiomyoma in a dog: case
report. Int J High Dilution Res [online]. 2008 [cited
2007 Feb 10]; 7(24):152-158. Available from:
http://www.feg.unesp.br/~ojs/index.php/ijhdr/articl
e/view/304/358.
Licensed to GIRI
Support: authors declare that this study received no funding
Conflict of interest: authors declare there is no conflict of interest
Received: 27 Aug 2008; Revised 12 Feb 2009; Published: 31 Mar 2009
Correspondence author: Luiz Figueira Pinto, luizfigueira@ufrrj.br
How to cite this article: Pinto LF. A case of idiopathic nephrotic syndrome treated with the homeopathic therapeutic. Int J
High Dilution Res [online]. 2009 [cited YYYY Mmm dd]; 8(26):26-32. Available from:
http://www.feg.unesp.br/~ojs/index.php/ijhdr/article/view/302/382
... alb. were effective in the treatment of Idiopathic NS. [8] Pai also showed the effects of homoeopathic medicines in paediatric NS cases. [9] This case report is an evidencebased, successfully managed case of NS with individualised homoeopathic medicine that otherwise would have been on lifelong immunosuppressant and corticosteroid dependency, known to have side effects. ...
Article
Full-text available
The most common vaginal neoplasias in old dogs are leiomyoma and fibroma. Although surgical excision is the indicated treatment, it does not eliminate potential complications that may lead to death or poor quality of life. This paper reports the case of a 9 year-old female Doberman dog with vaginal leiomyoma attended by copious and recidivating colporrhagia homeopathically treated between March and December 2005. Homeopathic approach was the one designed at Homeopathic Unit of the Veterinary Hospital, Rural Federal University of Rio de Janeiro, Brazil. The progress of disease was assessed through clinical evaluation, laboratory exams and ultrasonography. Hemorrhage decreased while the general clinical state of the animal improved. After 7 months of homeopathic treatment, the tumor was spontaneously eliminated through violent abdominal contractions, which was followed by recovery of the animal’s state of health. Keywords: Homeopathy; Veterinary medicine; Tumors; Leiomyoma; Vaginal; Dogs.  Tratamento homeopático de leiomioma vaginal em cães: relato de caso Resumo As neoplasias vaginais mais comuns em cadelas velhas são o leiomioma e o fibroma. Embora a excisão cirúrgica é o tratamento indicado, não elimina complicações potenciais que podem levar ao óbito ou baixa qualidade de vida. O presente artigo relata o caso de uma cadela Doberman de 9 anos de idade, com leiomioma vaginal, apresentando colporragia copiosa e recidivante, tratada entre março e dezembro de 2005. A abordagem homeopática utilizada foi a desenvolvida na Unidade Homeopática do Hospital Veterinário da Universidade Federal Rural do Rio de Janeiro, Brasil. A evolução da doença foi acompanhada através de avaliação clínica, testes de laboratório e ultrassonografia. A hemorragia diminuiu e o estado geral melhorou. Depois de 7 meses de tratamento homeopático, o tumor foi espontaneamente eliminado através de violentas contrações abdominais, seguido de recuperação do estado de saúde do animal. Palavras-chave: Homeopatia, Medicina Veterinária; Tumores; Leiomioma; Vaginal; Cães.  Tratamento homeopático de leiomioma vaginal en canino: relato de caso Resumen Las neoplasias vaginales más comunes en caninos ancianos son el leiomioma y el fibroma. Aunque la excisión quirúrgica es el tratamiento de elección, no elimina complicaciones potenciales que pueden llevar al deceso o pobre calidad de vida. Este artículo relata el caso de un canino Doberman femenino de 9 años de edad, con leiomioma vaginal acompañado de colporragia abundante y recidivante, tratado entre marzo y diciembre de 2005. El abordaje homeopático utilizado fue el desarrollado en la Unidad Homeopática del Hospital Veterinario de la Universidad Federal Rural de Río de Janeiro, Brasil. La evolución de la enfermedad fue estimada mediante evaluación clínica, exámenes de laboratorio y ecografía. Las hemorragias disminuyeron, con mejoría del estado general. Después de 7 meses de tratamiento homeopático, el tumor fue espontáneamente eliminado mediante violentas contracciones abdominales, seguido de recuperación del estado de salud del animal. Palabras-clave: Homeopatía, Medicina veterinaria; Tumores; Leiomioma; vaginal; Perros.  Correspondence author: Luiz Figueira Pinto. luizfigueira@ufrrj.br How to cite this article: Ferreira MIC, Pinto LF. Homeopathic treatment of vaginal leiomyoma in a dog: case report. Int J High Dilution Res [online]. 2008 [cited YYYY Mmm DD]; 7(24):152-158. Available from: http://journal.giri-society.org/index.php/ijhdr/article/view/304/358. ÂÂÂ
Article
Full-text available
Background While a number of reviews of homeopathic clinical trials have been done, all have used methods dependent on allopathic diagnostic classifications foreign to homeopathic practice. In addition, no review has used established and validated quality criteria allowing direct comparison of the allopathic and homeopathic literature. Methods In a systematic review, we compared the quality of clinical-trial research in homeopathy to a sample of research on conventional therapies using a validated and system-neutral approach. All clinical trials on homeopathic treatments with parallel treatment groups published between 1945–1995 in English were selected. All were evaluated with an established set of 33 validity criteria previously validated on a broad range of health interventions across differing medical systems. Criteria covered statistical conclusion, internal, construct and external validity. Reliability of criteria application is greater than 0.95. Results 59 studies met the inclusion criteria. Of these, 79% were from peer-reviewed journals, 29% used a placebo control, 51% used random assignment, and 86% failed to consider potentially confounding variables. The main validity problems were in measurement where 96% did not report the proportion of subjects screened, and 64% did not report attrition rate. 17% of subjects dropped out in studies where this was reported. There was practically no replication of or overlap in the conditions studied and most studies were relatively small and done at a single-site. Compared to research on conventional therapies the overall quality of studies in homeopathy was worse and only slightly improved in more recent years. Conclusions Clinical homeopathic research is clearly in its infancy with most studies using poor sampling and measurement techniques, few subjects, single sites and no replication. Many of these problems are correctable even within a "holistic" paradigm given sufficient research expertise, support and methods.
Article
The most common vaginal neoplasias in old dogs are leiomyoma and fibroma. Although surgical excision is the indicated treatment, it does not eliminate potential complications that may lead to death or poor quality of life. This paper reports the case of a 9 year-old female Doberman dog with vaginal leiomyoma attended by copious and recidivating colporrhagia homeopathically treated between March and December 2005. Homeopathic approach was the one designed at Homeopathic Unit of the Veterinary Hospital, Rural Federal University of Rio de Janeiro, Brazil. The progress of disease was assessed through clinical evaluation, laboratory exams and ultrasonography. Hemorrhage decreased while the general clinical state of the animal improved. After 7 months of homeopathic treatment, the tumor was spontaneously eliminated through violent abdominal contractions, which was followed by recovery of the animal's state of health.
Article
A series of 89 adult-onset nephrotic patients with minimal changes on renal biopsy was analyzed to compare the rate of response to corticosteroids and cytotoxic agents and the stability of remission or frequency of relapses at different ages. Severe hypertension and diminished renal function were more common in patients aged over 60 years, who formed 22.5% of the group. Seventy-five patients were given a first course of prednisolone in an initial dose of 60 mg/24 hr. After an eight week course of tapering doses of corticosteroids, only 45 of the 75 patients were in complete remission, 55 patients after 16 weeks and eventually 58 lost their proteinuria. The respective estimates of remission were 60%, 76% and 81%. Subsequently, of the 58 treated patients who responded, 24% never relapsed. Fifty-six percent of the patients relapsed on a single occasion or infrequently, and only 21% were frequent relapsers. Cyclophosphamide was used in 36 patients, in two as initial treatment, in 11 because of corticosteroid resistance, and in the remainder because of relapses. The time-course of loss of proteinuria was similar to that following treatment with corticosteroids, 25 (69%) losing proteinuria within 16 weeks. Only four patients failed to lose their nephrotic syndrome. Two of them had presented in acute renal failure and all four were over 60 years of age. The stability of remission after cyclophosphamide was better than that reported for children, only 13 of 36 showing relapses and 66% being in remission at five years, after which no further relapses were seen.(ABSTRACT TRUNCATED AT 250 WORDS)
Article
Most children with nephrotic syndrome do well, usually with multiple relapses and remissions. Some children require high doses of oral steroids to sustain a remission and develop significant steroid toxicity. These patients frequently can be managed with oral alkylating agents or with cyclosporine. A few nephrotic children to not respond to oral prednisone. The most common biopsy finding in steroid-resistant patients is focal segmental glomerulosclerosis. Many patients with this condition progress to chronic renal failure. Evidence suggests that the outcome is improved with either cyclosporine or with a protocol using pulse intravenous methylprednisolone and oral alkylating agents.
Article
The efficacy of homeopathic remedies has remained controversial. The homeopathic remedy most frequently studied in placebo-controlled clinical trials is Arnica montana. To systematically review the clinical efficacy of homeopathic arnica. Computerized literature searches were performed to retrieve all placebo-controlled studies on the subject. The following databases were searched: MEDLINE, EMBASE, CISCOM, and the Cochrane Library. Data were extracted in a predefined, standardized fashion independently by both authors. There were no restrictions on the language of publications. Eight trials fulfilled all inclusion criteria. Most related to conditions associated with tissue trauma. Most of these studies were burdened with severe methodological flaws. On balance, they do not suggest that homeopathic arnica is more efficacious than placebo. The claim that homeopathic arnica is efficacious beyond a placebo effect is not supported by rigorous clinical trials.
Article
The nephrotic syndrome, caused by glomerulonephritis, diabetes mellitus, or amyloidosis, is still a therapeutic challenge. Newer therapeutic approaches may be sought in the fields of immunosuppression, nonspecific supportive measures, heparinoid administration, and removal of a supposed glomerular basement membrane toxic factor. In immunosuppression, the newer drugs now used in organ transplantation (cyclosporine, tacrolimus, and mycophenolate mofetil) can also be used in the treatment of glomerulonephritis. In nonspecific supportive treatment, angiotensin II receptor antagonists are now used in addition to angiotensin-converting enzyme inhibitors. Positive effects of hydroxymethylglutaryl coenzyme A reductase inhibitors on the nephrotic syndrome have not yet been proven. Cyclooxygenase II inhibitors must be tested but probably have too many renal side effects, similar to those of nonsteroidal anti-inflammatory drugs. Heparinoids or glycosaminoglycans serve as polyanions and thus have protective effects on the negative charge of the glomerular basement membrane. They can now be administered as oral medications. The removal of a supposed glomerular basement membrane toxic factor that induces proteinuria has been attempted for 20 yr and now is usually performed using immunoadsorption. Especially in cases of recurrent nephrotic syndrome after renal transplantation for patients with glomerulonephritis, this approach has been successful in decreasing proteinuria, although in most cases its effect is not lasting but must be continuously renewed.
Article
Background: Idiopathic membranous nephropathy (IMN) is the most common form of nephrotic syndrome in adults. The disease shows a benign or indolent course in the majority of patients, with a rate of spontaneous complete or partial remission of nephrotic syndrome as high as 30% or more. Despite this, 30% to 40% of patients progress toward end-stage kidney disease (ESKD) within five to 15 years. The efficacy and safety of immunosuppression for IMN with nephrotic syndrome are still controversial. This is an update of a Cochrane review first published in 2004. Objectives: The aim of this review was to evaluate the safety and efficacy of immunosuppressive treatments for adult patients with IMN and nephrotic syndrome. Moreover it was attempted to identify the best therapeutic regimen, when to start immunosuppression and whether the above therapies should be given to all adult patients at high risk of progression to ESKD or only restricted to those with impaired kidney function. Search methods: We searched Cochrane Renal Group Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, Chinese databases, reference lists of articles, and clinical trial registries to June 2014. We also contacted principal investigators of some of the studies for additional information. Selection criteria: Randomised controlled trials (RCTs) investigating the effects of immunosuppression in adults with IMN and nephrotic syndrome. Data collection and analysis: Study selection, data extraction, quality assessment, and data synthesis were performed using the Cochrane-recommended methods. Summary estimates of effect were obtained using a random-effects model, and results were expressed as risk ratios (RR) and their 95% confidence intervals (CI) for dichotomous outcomes, and mean difference (MD) and 95% CI for continuous outcomes. Main results: Thirty nine studies with 1825 patients were included, 36 of these could be included in our meta-analyses. The data from two studies could not be extracted and one study was terminated due to poor accrual. Immunosuppression significantly reduced all-cause mortality or risk of ESKD ((15 studies, 791 patients): RR 0.58 (95% CI 0.36 to 0.95, P = 0.03) and risk of ESKD ((15 studies, 791 patients): RR 0.55, 95% CI 0.31 to 0.95, P = 0.03), increased complete or partial remission ((16 studies, 864 patients): RR 1.31, 95% CI 1.01 to 1.70, P = 0.04), and decreased proteinuria ((9 studies,(393 patients): MD -0.95 g/24 h, 95% CI -1.81 to -0.09, P = 0.03) at the end of follow-up (range 6 to 120 months). However this regimen was associated with more discontinuations or hospitalisations ((16 studies, 880 studies): RR 5.35, 95% CI 2.19 to 13.02), P = 0.0002). Combined corticosteroids and alkylating agents significantly reduced death or risk of ESKD ((8 studies, 448 patients): RR 0.44, 95% CI 0.26 to 0.75, P = 0.002) and ESKD ((8 studies, 448 patients): RR 0.45, 95% CI 0.25 to 0.81, P = 0.008), increased complete or partial remission ((7 studies, 422 patients): RR 1.46, 95% CI 1.13 to 1.89, P = 0.004) and complete remission ((7 studies, 422 patients): RR 2.32, 95% CI 1.61 to 3.32, P < 0.00001), and decreased proteinuria ((6 studies, 279 patients): MD -1.25 g/24 h, 95% CI -1.93 to -0.57, P = 0.0003) at the end of follow-up (range 9 to 120 months). In a population with an assumed risk of death or ESKD of 181/1000 patients, this regimen would be expected to reduce the number of patients experiencing death or ESKD to 80/1000 patients (range 47 to 136). In a population with an assumed complete or partial remission of 408/1000 patients, this regimen would be expected to increase the number of patients experiencing complete or partial remission to 596/1000 patients (range 462 to 772). However this combined regimen was associated with a significantly higher risk of discontinuation or hospitalisation due to adverse effects ((4 studies, 303 patients): RR 4.20, 95% CI 1.15 to 15.32, P = 0.03). Whether this combined therapy should be indicated in all adult patients at high risk of progression to ESKD or only restricted to those with deteriorating kidney function still remained unclear. Cyclophosphamide was safer than chlorambucil ((3 studies, 147 patients): RR 0.48, 95% CI 0.26 to 0.90, P = 0.02). There was no clear evidence to support the use of either corticosteroid or alkylating agent monotherapy. Cyclosporine and mycophenolate mofetil failed to show superiority over alkylating agents. Tacrolimus and adrenocorticotropic hormone significantly reduced proteinuria. The numbers of corresponding studies related to tacrolimus, mycophenolate mofetil, adrenocorticotropic hormone, azathioprine, mizoribine, and Tripterygium wilfordii are still too sparse to draw final conclusions. Authors' conclusions: In this update, a combined alkylating agent and corticosteroid regimen had short- and long-term benefits on adult IMN with nephrotic syndrome. Among alkylating agents, cyclophosphamide was safer than chlorambucil. This regimen was significantly associated with more withdrawals or hospitalisations. It should be emphasised that the number of included studies with high-quality design was relatively small and most of included studies did not have adequate follow-up and enough power to assess the prespecified definite endpoints. Although a six-month course of alternating monthly cycles of corticosteroids and cyclophosphamide was recommended by the KDIGO Clinical Practice Guideline 2012 as the initial therapy for adult IMN with nephrotic syndrome, clinicians should inform their patients of the lack of high-quality evidence for these benefits as well as the well-recognised adverse effects of this therapy. Cyclosporine or tacrolimus was recommended by the KDIGO Clinical Practice Guideline 2012 as the alternative regimen for adult IMN with nephrotic syndrome; however, there was no evidence that calcineurin inhibitors could alter the combined outcome of death or ESKD.
Homeopatia em 1000 conceitos
  • Kossak
  • A Romanach
Kossak-Romanach A. Homeopatia em 1000 conceitos. 3rd ed, São Paulo (Brazil): Elcid; 2003.
The law of similarity, dissimilarity and physiology – The principles for the comprehension of chronic diseases and their homeopathic treatment
  • Carillo Junior
Carillo Junior R. The law of similarity, dissimilarity and physiology – The principles for the comprehension of chronic diseases and their homeopathic treatment. Braz Homeopathic J. 2002; 8(2): 92-102.